Quintrio
Home

Stock overview

Park Ha Biological Technology Co., Ltd. Ordinary Shares

BYAH

Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.

Last trade $1.58
Day change +$0.10 (+6.76%)
Day range $1.29 – $2.18
Volume 748,246
Market cap $1M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for BYAH.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for BYAH.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) alleging securities fraud. The complaint claims the company made false and misleading statements, failed to disclose a fraudulent stock promotion and market manipulation scheme involving social media misinformation, and intentionally structured its IPO with an extremely low public float to facilitate manipulation. Investors who purchased Park Ha securities between December 27, 2024 and July 8, 2025 are encouraged to join the case, with a lead plaintiff deadline of September 28, 2026.

GlobeNewswire Inc.

PHH, BYAH DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH

A securities class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. for allegedly making materially false statements and failing to disclose a fraudulent stock promotion scheme involving social media misinformation and artificially manipulated trading activity. Investors who purchased securities between December 27, 2024 and July 8, 2025 are encouraged to seek legal counsel before the September 28, 2026 lead plaintiff deadline.

GlobeNewswire Inc.

PHH, BYAH FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH

Rosen Law Firm announces a securities class action lawsuit against Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) for investors who purchased securities between December 27, 2024 and July 8, 2025. The lawsuit alleges that defendants made materially false statements and failed to disclose a fraudulent stock promotion scheme involving social media misinformation, impersonated financial professionals, and artificially manipulated trading activity. The lead plaintiff deadline is September 28, 2026.

GlobeNewswire Inc.

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lincoln Educational Services Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - LINC

Rosen Law Firm has filed class action lawsuits against Lincoln Educational Services Corporation and other companies on behalf of investors who purchased securities during specified periods. The lawsuit alleges that Lincoln Educational Services made false statements about its admissions process and student conversion rates, resulting in misleading statements about business operations and prospects. Investors who purchased securities during the class period may be entitled to compensation.

GlobeNewswire Inc.

PHH, BYAH DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH

Rosen Law Firm announces securities class action lawsuits against Park Ha Biological Technology Co., Ltd. (PHH, BYAH), ARS Pharmaceuticals, Inc. (SPRY), and Beta Bionics, Inc. (BBNX). The firm is seeking lead plaintiffs with losses exceeding $100,000 before the September 28, 2026 deadline. Park Ha faces allegations of fraudulent stock promotion schemes, misleading statements, and artificially manipulated trading activity.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Aug 6, 20261-for-8reverse split
Feb 20, 20261-for-50reverse split